Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Merck?s dual combination hepatitis C therapy boasted near-perfect cure rates in an early trial including people with genotypes 1a and 1b.
Vertex Pharmaceuticals has entered a non-exclusive partnership with Bristol-Myers Squibb to study Vertexâ€™s VX-135 with BMSâ€™s dac...
Long-term studies have found that Isentress is both safe and effective in suppressing HIV among adult patients coinfected with hepatitis B, C...
Gilead Sciences? pair of investigatory hepatitis C virus therapies led to a 100 percent cure rate among a small cohort of patients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.